Theravance Biopharma Inc (TBPH) — Financial Flexibility Index
Theravance Biopharma Inc (TBPH) has a Financial Flexibility Index of -0.03x as of December 2025. Free cash flow of $-6.06 Million (operating CF $-6.06 Million minus capex $8.00K) represents 0% of total liabilities ($188.85 Million). Also explore how fast is Theravance Biopharma Inc growing its equity to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Theravance Biopharma Inc Financial Flexibility Index (2011–2025)
Historical Financial Flexibility Index trend for Theravance Biopharma Inc across 15 annual periods. Check Theravance Biopharma Inc (TBPH) strategic investment index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Theravance Biopharma Inc (2011–2025)
Year-by-year free cash flow to debt coverage for Theravance Biopharma Inc. For the full company profile including market capitalisation, see Theravance Biopharma Inc (TBPH) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.26x | $238.58 Million | $238.54 Million | $188.85 Million | ▲ +2114.3% |
| 2024 | -0.06x | $-11.20 Million | $-11.54 Million | $178.62 Million | ▲ +56.8% |
| 2023 | -0.15x | $-24.51 Million | $-27.00 Million | $169.00 Million | ▲ +87.1% |
| 2022 | -1.13x | $-186.42 Million | $-186.99 Million | $165.60 Million | ▼ -292.8% |
| 2021 | -0.29x | $-204.45 Million | $-207.86 Million | $713.39 Million | ▲ +9.2% |
| 2020 | -0.32x | $-243.79 Million | $-250.40 Million | $772.81 Million | ▲ +15.1% |
| 2019 | -0.37x | $-235.02 Million | $-238.20 Million | $632.67 Million | ▼ -115.2% |
| 2018 | -0.17x | $-105.63 Million | $-112.87 Million | $611.82 Million | ▲ +71.6% |
| 2017 | -0.61x | $-198.65 Million | $-201.05 Million | $326.22 Million | ▼ -81.7% |
| 2016 | -0.34x | $-96.85 Million | $-98.99 Million | $289.02 Million | ▲ +88.5% |
| 2015 | -2.91x | $-166.21 Million | $-168.86 Million | $57.05 Million | ▲ +18.7% |
| 2014 | -3.59x | $-172.05 Million | $-175.16 Million | $47.98 Million | ▼ -28.0% |
| 2013 | -2.80x | $-118.22 Million | $-120.96 Million | $42.21 Million | ▲ +45.5% |
| 2012 | -5.14x | $-116.52 Million | $-119.11 Million | $22.67 Million | ▼ -895.3% |
| 2011 | -0.52x | $-79.80 Million | $-83.43 Million | $154.54 Million | — |